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We have greatly enjoyed reading the recently published
manuscript by Siciliano et al. entitled ‘‘Incremental value of
B-type natriuretic peptide for early risk prediction of infective
endocarditis’’.1 We thank them for sharing their experience;
however, we have some concerns about the article. The mortality
associated with infective endocarditis (IE) is relatively high, and a
rapid diagnosis and prediction of prognosis is essential to facilitate
effective treatment. However, identifying patients at increased risk
of adverse outcomes is challenging in IE due to the broad spectrum
of the cardiac pathology and infecting microorganisms. Several
biomarkers have been examined for their efﬁcacy to predict
outcome and assess prognosis of IE patients. Two previous pilot
studies showed that B-type natriuretic peptide (BNP) levels
obtained on admission are signiﬁcantly higher in patients with
IE who died as compared to survivors.2,3 Siciliano and colleagues
also provided incremental values of BNP levels obtained on
admission for the early risk prediction of in-hospital mortality in
an unselected patient population with IE. However, the major
drawbacks of the study are the observational design and the lack of
systematic collection of BNP data on all enrolled subjects. As the
clinical and laboratory differences between patients with and
without BNP measurements are not mentioned, there may be a
selection bias among study subjects. Kahveci and Shiue found that
the addition of troponin to BNP provided incremental prognostic
value, and patients with IE who had concomitant elevations of
troponin and BNP were at particularly high risk for poor
outcomes.2,3 Moreover, none of the patients with either BNP or
troponin elevation experienced the primary end points in both
studies. Therefore, we would be grateful if the authors have andhttp://dx.doi.org/10.1016/j.ijid.2014.11.013
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/4.0/).would provide the data regarding troponin levels on admission in
patients with IE.
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